Startups

Setpoint: Finance Infrastructure Provider Company Secures $31 Million (Series B)

By Amit Chowdhry ● Aug 13, 2024

Setpoint, a leading infrastructure provider for the credit industry, announced today the successful completion of its $31 million Series B funding round. 645 Ventures led the round, with significant strategic investments from Citi and Wells Fargo, alongside Andreessen Horowitz, NextView Ventures, Floating Point, Henry Kravis, Zillow founder’s 75 & Sunny, Vesta Ventures, Fifth Wall, Eltura Ventures, and Outrunner Capital.

Guidewheel: AI-Based FactoryOps Company Closes $31 Million (Series B)

By Amit Chowdhry ● Aug 13, 2024

Guidewheel, a leader in AI-powered FactoryOps, raised an oversubscribed $31 million Series B funding round led by Decarbonization Partners, a partnership between BlackRock and Temasek. And Ecolab, Rethink Impact, and GSBackers also participated in this round, along with existing investors Greycroft and Breakthrough Energy Ventures (BEV).

Mechanical Orchard: $50 Million (Series B)‍ Raised To Help Companies Transition Away From Legacy Software

By Amit Chowdhry ● Aug 13, 2024

Mechanical Orchard, a technology business reinventing the software that runs the world, announced it has raised $50 million in a Series B funding round led by GV.

Prana Thoracic: MedTech Company Closes $3 Million (Series A Extension)

By Amit Chowdhry ● Aug 13, 2024

Prana Thoracic, a Houston-based medical tech company created with a vision to transform lung cancer intervention, announced the successful final closing of its Series A extension round. The company initially raised $3 million, received a non-dilutive grant of $3 million, and has now closed on an additional $3 million in oversubscribed funding.

Myrobalan Therapeutics: Additional $9 Million Raised And Grant Bogle Joins Board

By Amit Chowdhry ● Aug 13, 2024

Myrobalan Therapeutics, a biotechnology company developing novel oral small-molecule therapies to repair damage and restore brain function in high-unmet need central nervous system (CNS) conditions, announced the appointment of Grant C. Bogle to its Board of Directors. Mr. Bogle is a seasoned biotech executive with over three decades of operational experience in the biopharma industry and a strong focus on financial strategy, business development, corporate governance, and general management.

IDRx Raises $120 Million To Transform Cancer Treatment With Precision Therapies

By Amit Chowdhry ● Aug 13, 2024

IDRx (a clinical-stage biopharmaceutical company dedicated to transforming cancer treatment with purpose-built precision therapies) announced the completion of an oversubscribed $120 million Series B Preferred Stock financing. This financing was led by RA Capital Management, Commodore Capital, and Blackstone Multi-Asset Investing, with additional new investors, including Rock Springs Capital and a U.S.-based healthcare-focused fund. Existing investors, including Andreessen Horowitz (a16z) Bio + Health, Casdin Capital, Nextech Invest (on behalf of one or more managed funds), Forge Life Science Partners, co-founder Nick Lydon, Ph.D., and strategic partner Merck KGaA, Darmstadt, Germany also participated in the funding.

Datch: Frontline Intelligence Company Raises $15 Million (Series A)

By Amit Chowdhry ● Aug 13, 2024

Datch, an AI-based frontline manufacturing, energy, and utility sector pioneer, announced the closing of a $15 million Series A via an extension led by Third Prime. This funding round also coincides with Datch’s latest product offering, Asset Insights.